Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 02/21/2025 | PUT | $245.00 | 694 | +497 | +252.28% |
| 01/10/2025 | CALL | $275.00 | 598 | +294 | +96.71% |
| 06/20/2025 | PUT | $250.00 | 496 | +167 | +50.76% |
| 02/21/2025 | CALL | $285.00 | 2,771 | +137 | +5.20% |
| 01/31/2025 | PUT | $250.00 | 184 | +133 | +260.78% |
| 01/10/2025 | PUT | $265.00 | 135 | +104 | +335.48% |
| 06/20/2025 | CALL | $320.00 | 374 | -30 | -7.43% |
| 06/20/2025 | PUT | $320.00 | 96 | -41 | -29.93% |
| 03/21/2025 | CALL | $290.00 | 1,667 | -42 | -2.46% |
| 01/10/2025 | CALL | $257.50 | 84 | -48 | -36.36% |
| 01/10/2025 | PUT | $257.50 | 507 | -98 | -16.20% |
| 01/17/2025 | PUT | $240.00 | 1,450 | -137 | -8.63% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.04% | 16.22M | 3.66B |
| Vanguard 500 Index Fund | 2.31% | 12.33M | 2.78B |
| Vanguard/Primecap Fund | 1.71% | 9.12M | 2.06B |
| Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 1.31% | 7.02M | 1.58B |
| Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF | 1.25% | 6.7M | 1.51B |
| Fidelity 500 Index Fund | 1.09% | 5.85M | 1.32B |
| SPDR S&P 500 ETF Trust | 1.08% | 5.78M | 1.3B |
| SPDR Dow Jones Industrial Average ETF | 1.05% | 5.6M | 1.26B |
| iShares Core S&P 500 ETF | 0.89% | 4.76M | 1.07B |
| Capital Income Builder, Inc. | 0.89% | 4.74M | 1.07B |
Immunotoxins Market Trends and Regional Business Opportunities, 2024-2034: Diphtheria Toxin-Based Immunotoxins Lead Revenue, Pseudomonas Exotoxins Show Rapid Growth Potential
01/09 05:52 am
GlobeNewswire Inc.
Read morePrediction: These 3 Healthcare Stocks Will Soar in 2025
01/04 07:48 am
The Motley Fool
Read moreShould You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
01/03 09:30 am
The Motley Fool
Read more1 Beaten-Down Stock That Could Soar by 50% in 2025, According to Wall Street
01/02 11:00 am
The Motley Fool
Read moreBurkitt Lymphoma Global Clinical Trials Review 2024: Clinical Trials by Region, Country, Trial Status, Trial Phase, Sponsor Type and End Point Status
12/23 01:44 pm
GlobeNewswire Inc.
Read more2 Excellent Dividend Stocks to Buy on the Dip
12/23 05:32 am
The Motley Fool
Read moreWhat's Going On With Amgen Stock On Friday?
12/20 03:40 pm
Benzinga
Read moreComprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight
12/19 02:00 pm
GlobeNewswire Inc.
Read moreThese Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over
12/12 03:23 pm
The Motley Fool
Read moreAMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND
12/10 05:30 pm
Benzinga
Read moreCancer Monoclonal Antibodies Market to Grow at a 18.4% CAGR through 2031 | SkyQuest Technology
12/09 08:10 am
Benzinga
Read moreCD40 Targeted Therapies Clinical Trials & Market Opportunity Report 2025, Insight By Company, Country, Indication & Phase
12/09 05:48 am
GlobeNewswire Inc.
Read more2 No-Brainer Dividend Stocks With Yields Over 3% to Buy in 2025 and Hold for a Decade or Longer
12/09 05:36 am
The Motley Fool
Read moreShould You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
12/07 11:39 am
The Motley Fool
Read moreIs Amgen Still a Top Dividend Stock?
12/05 08:28 am
The Motley Fool
Read moreEli Lilly Just Got a Bundle of Good News: Time to Buy?
12/04 08:10 am
The Motley Fool
Read moreDown 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?
11/30 07:20 am
The Motley Fool
Read moreIs Novo Nordisk Stock a Buy?
11/29 06:35 am
The Motley Fool
Read moreIs Amgen Stock Still a Buy After an Unexpected Reveal of Data?
11/29 05:28 am
The Motley Fool
Read morePersonalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology
11/26 08:30 pm
Benzinga
Read morePersonalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology
11/26 08:30 pm
GlobeNewswire Inc.
Read moreStocks Mixed Ahead Of Fed Minutes, Mexican Peso Tumbles To Over 2-Year Lows On Tariffs Fears: What's Driving Markets Tuesday?
11/26 02:27 pm
Benzinga
Read moreInvesting in Pharma Stocks? Check These 3 Things First
11/22 10:15 am
The Motley Fool
Read moreIntravenous Solutions Market to Surpass USD 23.96 Billion by 2031 | SkyQuest Technology
11/19 06:41 am
Benzinga
Read more2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious
11/16 09:45 am
The Motley Fool
Read more2 Dividend Stocks to Buy Hand Over Fist in November
11/14 11:15 am
The Motley Fool
Read moreAstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis
11/08 09:47 am
Benzinga
Read more3 Potential Catalysts That Could Lift Pfizer Stock Before 2025
11/03 09:33 am
The Motley Fool
Read more2 Reliable Dividend Stocks You Can Buy and Hold Forever
10/26 04:30 am
The Motley Fool
Read moreIs Amgen Stock a Buy?
10/18 07:32 am
The Motley Fool
Read moreShifts in the Psoriasis Market Suggest Strong Potential for Emerging Oral Therapies
10/16 02:48 pm
GlobeNewswire Inc.
Read moreChemotherapy Drugs Market Report 2024: Essential Growth Dynamics and Advancements to 2030
10/14 10:54 am
GlobeNewswire Inc.
Read moreBispecific Antibody Drug Conjugates Market Opportunity Outlook 2024-2029: China Leads Over 35 Candidates, Key Companies Pioneering BsADC are Amgen, Innovent Biologics, AstraZeneca
10/14 05:52 am
GlobeNewswire Inc.
Read more2 Top Dividend Stocks to Buy Hand Over Fist Right Now
10/11 06:30 am
The Motley Fool
Read more2 Biotech Stocks to Buy Hand Over Fist in October
10/09 10:15 am
The Motley Fool
Read moreGermany Pharmaceuticals Market Report 2024-2028: Consolidation through Mergers and Acquisitions Catalyzing Growth
10/09 06:43 am
GlobeNewswire Inc.
Read moreWant to Invest in the Weight Loss Boom? Consider Buying These 2 Stocks
10/08 06:30 am
The Motley Fool
Read more3 Magnificent Dividend Stocks to Buy in October
10/06 05:50 am
The Motley Fool
Read more3 Reasons to Buy BioAge Labs Stock Hand Over Fist in October
10/05 07:15 am
The Motley Fool
Read moreShould You Buy the Dip on This Top Growth Stock?
10/05 06:30 am
The Motley Fool
Read moreGlobal Inhalable Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight
10/03 01:00 pm
GlobeNewswire Inc.
Read moreMoore Law, PLLC Encourages Amgen, Inc. Investors to Contact Law Firm
10/02 06:29 pm
GlobeNewswire Inc.
Read moreFederal Judge Rules Amgen Must Face Tax Liability Lawsuit That Alleges Reckless Concealment Of $10.7B Tax Bill
10/02 01:34 pm
Benzinga
Read morePrediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason
09/27 03:50 am
The Motley Fool
Read moreAmgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs
09/25 01:30 pm
Benzinga
Read moreAmgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
09/25 08:04 am
Benzinga
Read moreWearable Injectors Market to Reach USD 23.89 Billion by 2031 | SkyQuest Technology
09/24 08:30 am
Benzinga
Read moreAmgen vs. Viking Therapeutics: What's the Better GLP-1 Stock to Buy?
09/23 07:30 am
The Motley Fool
Read moreThis 1 Simple ETF Could Turn $500 a Month Into $500,000
09/21 08:26 am
The Motley Fool
Read more